Wide Moat ETF Sees Companies as Castles
Just like a moat surrounds and protects a castle, so does an economic “moat” surround and protect a firm from competitors.
Companies Squeeze 401(k)s From Facebook to JPMorgan
Employers are holding back on both the amount and the timing of 401(k) matching funds and dragging out vesting schedules.
Supreme Court Backs 5-Year Limit on Securities Fraud Cases
The Supreme Court issued two rulings on Wednesday: one stating that the SEC must bring securities fraud cases within five years of when the fraud occurred, and another making it easier for shareholders to bring class-action lawsuits.
Top 8 Most Overpaid CEOs of Public Companies
Some CEOs keep raking in the bucks even as the companies they lead lose market share, see their stock price fall, or both.
Fund in Focus: Permanent Aggressive Growth Portfolio
Michael J. Cuggino, manager since January 1991 S&P Rank: 4 Stars Aggressive Growth Fund Takes The Long View
Fund in Focus: Constellation Sands Capital Select Growth
Frank Sands Jr., manager since July 2000 S&P Rank: 3 Stars Bulking Up On Biotech
Evan McCulloch of Franklin Biotechnology Discovery Fund
S&P Rank: 3 Stars March 11, 2004 Biotechs High on Drug Approvals
Liu-Er Chen of Evergreen Health Care Fund
S&P Rank: 4 Stars Aug. 14, 2003 On the Cusp of a New Drug Boom Quick Take: Drug and biotech stocks suffered in 2002, hurt by poor earnings,...
Evan McCulloch of Franklin Biotechnology Discovery
S&P Rank: 3 Stars Strong Dose of Biotech